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SHORT COMMUNICATION
Differential timing of antibody-mediated phagocytosis
and cell-free killing of invasive African Salmonella
allows immune evasion
Matthew K. Siggins1,2, Colette M. O’Shaughnessy1, John Pravin1,
Adam F. Cunningham1, Ian R. Henderson1, Mark T. Drayson1
and Calman A. MacLennan1,2
1 Medical Research Council Centre for Immune Regulation and Clinical Immunology Service,
Institute of Biomedical Research, School of Immunity and Infection, College of Medicine and
Dental Sciences, University of Birmingham, Birmingham, UK
2 Novartis Vaccines Institute for Global Health, Siena, Italy
Nontyphoidal Salmonellae commonly cause fatal bacteraemia in African children lacking
anti-Salmonella antibodies. These are facultative intracellular bacteria capable of cell-free
and intracellular survival within macrophages. To better understand the relationship
between extracellular and intracellular infection in blood and general mechanisms of Ab-
related protection against Salmonella, we used human blood and sera to measure kinetics
of Ab and complement deposition, serum-mediated bactericidal killing and phagocytosis
of invasive African Salmonella enterica serovar Typhimurium D23580. Binding of antibod-
ies peaked by 30 s, but C3 deposition lagged behind, peaking after 2–4 min. C5b-9 depo-
sition was undetectable until between 2 and 6 min and peaked after 10 min, after which
time an increase in serum-mediated killing occurred. In contrast, intracellular, opsonized
Salmonellae were readily detectable within 5 min. By 10 min, around half of mono-
cytes and most neutrophils contained bacteria. The same kinetics of serum-mediated
killing and phagocytosis were observed with S. enterica Typhimurium laboratory strain
SL1344, and the S. enterica Enteritidis African invasive isolate D24954 and laboratory
strain PT4. The differential kinetics between cell-free killing and phagocytosis of invasive
nontyphoidal Salmonella allows these bacteria to escape the blood and establish intracel-
lular infection before they are killed by the membrane attack complex.
Keywords: Antibodies · Complement · Opsonization · Phagocytosis · Salmonella
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Immunity against the facultative intracellular bacterium
Salmonella is complex, involving both cellular [1,2] and humoral
mechanisms [3]. Nontyphoidal Salmonellae (NTS), particu-
Correspondence: Prof. Calman A. MacLennan
e-mail: calman.maclennan@novartis.com
larly Salmonellae enterica serovar Typhimurium and Enteritidis
(S. Typhimurium and S. Enteritidis) are a major, yet neglected,
cause of fatal bacteraemia in Africa [4,5]. Among young children
in sub-Saharan Africa, the period of susceptibility to invasive NTS
infections coincides with the loss of maternally acquired IgG prior
to the acquisition of the child’s own anti-Salmonella IgM and IgG.
A lack of specific antibodies in African infants is associated with
fatal invasive Salmonella disease [6]. In vitro work demonstrates
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potentially important roles for both complement-fixing bacterici-
dal antibodies [6] and opsonizing antibodies [7] in African chil-
dren, and the majority of invasive NTS isolates in Malawi are
sensitive to Ab-mediated killing in serum [6].
Although in healthy adults in developed countries nonty-
phoidal salmonellosis is usually a self-limiting gastrointestinal
infection [8], deficiencies in or immaturity of immunity can lead
to severe Salmonella disease. Individuals with defects in the
IL-12/23-IFN-γ axis, which affects killing of Salmonella within
phagocytes, typically develop severe, though nonfatal, recurrent
focal infection in lymph nodes, despite the presence of specific
antibodies [1,9]. This suggests that appropriate Ab responses can
help prevent the uncontrolled expansion of Salmonella numbers
even in individuals with marked immunodeficiencies, although
antibodies alone are insufficient to resolve infection.
Proliferation, spread, and distribution of Salmonellaewithin the
host is heterogeneous and not fully understood. Current models of
NTS infection in mice indicate that upon infection, a proportion of
Salmonellae gain access to the bloodstream where complement-
mediated clearance occurs [10], while some gain direct access
from the gastrointestinal tract into phagocytes via M cells. Once
intracellular infection has been established, spread from infected
to uninfected phagocytes is likely to occur through cell necrosis
and/or apoptosis. Necrosis of infected cells will release individual
bacteria into the extracellular space [11].
Hence, a proportion of Salmonellae are likely to be, at least
transiently, present in the extracellular space and blood, where
they are exposed to humoral components of the immune sys-
tem. Ab-dependent complement-mediated killing of extracellular
Salmonellae appears to be minimal in mice [12], but important in
humans [6,13]. As most work on the dissemination of Salmonellae
within a host has been performed in mouse models, the contribu-
tion of cell-free complement killing to the dynamics of infection
may be underestimated.
Here we have performed serum bactericidal, phagocytosis,
Ab-binding, and complement-deposition time-course assays with
human blood and sera in order to better understand the rela-
tionship between extracellular killing and uptake into phagocytic
cells of invasive African NTS in humans. This demonstrates that
uptake of Salmonella into the intracellular niche of phagocytic cells
can occur before cell-free Ab-mediated killing of bacteria is fully
established, allowing a portal through which bacteria can evade
extracellular killing.
Results and discussion
Deposition of antibodies and complement on
Salmonella occurs rapidly in serum
In humans, optimal cell-free killing and phagocytosis of Salmonella
requires deposition of antibodies and complement [6,7].We inves-
tigated the kinetics of binding and deposition of Ab and comple-
ment on the bacterial surface. IgG deposition on S. Typhimurium
D23580 was rapid for all sera and reached peak levels within
30 s (Fig. 1A), although the maximal IgG binding varied between
Figure 1. Time course of binding of IgG and deposition of comple-
ment components on S. TyphimuriumD23580 in human serumAfrican
S.TyphimuriumD23580was incubated in undilutedhuman serum from
four healthy adults for the indicated time points and (A) IgG, (B) C3, and
(C) MAC deposition were measured by flow cytometry. Each line style
represents the same donor in each panel. Data for each donor were
pooled from three independent experiments in which each donor was
tested in triplicate and are shown as mean ± SD of geometric MFI.
donors. The maximum deposition of the most abundant comple-
ment component, C3, occurred at 2–4 min and so lagged behind
IgG binding (Fig. 1B).
While the rate of C3 deposition varied between donors, the
rank order for the four donors corresponded to the rank order
of IgG deposition levels. Nevertheless, by the end of the assay at
10 min, C3 levels on bacteria were comparable between donors.
Thus, levels of IgG deposition correspond more closely with the
rate of C3 deposition than the final amount of C3 deposited.
Percentages of Salmonellae labeled with IgG and C3 correlated
strongly with the geometric mean IgG and C3 deposited on the
bacteria, respectively (Spearman correlation r >0.9, p < 0.0001
for both comparisons) (Supporting Information Fig. 1A–D).
Formation of bactericidal membrane attack
complexes lags behind opsonization of Salmonellae
Ab-directed complement-mediated killing of S. Typhimurium
D23580 is associated with the deposition of terminal complement
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factors to form the bactericidal C5b-9 membrane attack complex
(MAC) [6]. Sera lacking specific antibodies are unable to kill
S. Typhimurium [6] and MAC deposition correlates with IgG
binding [14]. In each serum tested, C5b-9 deposition on
S. Typhimurium developed at a rate that was slower than both
IgG binding and C3 deposition (Fig. 1C), with rank order of C5b-9
deposition rate in serum again corresponding to the rank order
of IgG binding. Varying between donors, C5b-9 deposition was
first detectable at 2–6 min and had not reached a maximum until
10 min. Therefore, although Ab binding is rapid, there can be a lag
phase before the machinery that enables cell-free killing is assem-
bled. As for IgG and C3, the percentage of Salmonellae labeled
with MAC correlated strongly with geometric mean MAC depo-
sition (Spearman correlation r >0.9, p < 0.0001) (Supporting
Information Fig. 1E and F).
Cell-free killing of Salmonellae by serum follows an
initial lag period
Despite the varying rate of deposition of C5b-9 between donors,
in all cases serum-mediated killing was limited within the first
5–10 min of the assay (Fig. 2A). After this time there was an
increase in the rate of Salmonella killing. Such an initial latent
period has been observed for other bacterial species and could
correspond to the time required for the assembly of the MAC [13].
Our data are consistent with this concept, since maximal serum-
mediated killing only occurred after a threshold level of MAC
deposition had been exceeded and we have previously reported
such a threshold effect [6]. Alternatively, killing could relate to the
number of MAC-induced membrane punctures required to cause
irreversible damage to the bacterium.
Serum bactericidal assay (SBA) with heat-inactivated serum
resulted in no bacterial killing, indicating that killing is
complement-mediated and that bacterial agglutination had not
led to an artifactual reduction in viable counts. In order to ensure
that error was not introduced into the study due to differences
in the concentrations of bacteria used in SBA (1 × 106/mL)
and flow cytometric assays to assess Ig and complement differ-
ence and phagocytosis (2.0–3.3 × 108/mL), we repeated the SBA
using initial concentrations of 1 × 106, 1 × 107, and 1 × 108/mL
S. Typhimurium D23580. There was no significant difference in
the killing of Salmonella with the three different starting concen-
trations of bacteria (Supporting Information Fig. 2A). Notably, no
net decrease in bacterial numbers was observed during the first
10 min of the assay with any of the three starting concentrations
of Salmonella.
Our findings are consistent with IgG increasing the efficiency
of complement deposition. Removal of Salmonella-specific IgG
by adsorption abrogated the binding of C3 and deposition of
MAC, preventing serum-mediated killing of Salmonella (Support-
ing Information Fig. 3). Killing could be restored by supplementing
with heat-inactivated serum as a source of Ab. However, higher
levels of Salmonella-specific IgG did not necessarily alter the kinet-
ics of cell-free killing. After this lag time, killing progressed readily
and once established there was some relationship between levels
Figure 2. In vitro time course of serum killing and peripheral blood
cell phagocytosis of S. Typhimurium. African S. Typhimurium D23580
was exposed to undiluted serum and whole blood from four healthy
adult donors for the indicated time points. (A) Serum killing of D23580
was determined by serum bactericidal assay, and phagocytosis of FITC-
labeledD23580 by (B) neutrophils and (C)monocytes inwhole bloodwas
measured by flow cytometry. Each line style represents the same donor
as in Figure 1. Data for each donor were pooled from three independent
experiments inwhich each donorwas tested in triplicate and are shown
as mean ± SD.
of IgG deposition and the speed and extent of bacterial killing
(Fig. 2A). Serum-mediated killing continued throughout the entire
time course of 45 min. Overall, there was a lack of clear correla-
tion between ranked killing rate and binding and deposition of
IgG, C3, and MAC, although the serum with the highest associ-
ated Ab and complement deposition affected both the quickest
serum-mediated killing and phagocytosis of Salmonellae.
Phagocytosis of Salmonellae by neutrophils and
monocytes initiates rapidly
Phagocytosis by neutrophils (Fig. 2B) and monocytes (Fig. 2C),
determined as the percentage of each cell type with internalized
FITC-labeled S. Typhimurium, began within the first 5 min of
exposure to blood. This intracellular uptake of opsonized bacteria
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into phagocytes occurred before cell-free complement-mediated
killing was fully established and before maximum levels of C5b-9
depositionwere detectable. In contrast, by this time there had been
up to a 100-fold increase in levels of C3 deposition following Ab
binding. In the absence of Ab and complement for opsonization,
no uptake into neutrophils or monocytes was observed.
Although Salmonellae possess mechanisms that enable eva-
sion of killing within phagocytes, previous work has indicated
that S. Typhimurium 14028s opsonized with IgG is targeted
to the lysosomal compartment of DCs for degradation through
FcγRIII-dependent [15] and FcγR-independent mechanisms [16].
Similarly, engagement of FcR on macrophages by antibodies
bound to Legionella pneumophila and Mycobacterium bovis bacil-
lus Calmette-Gue´rin targets these pathogens to lysosomes [17]. A
study of survival of S. Typhimurium SL1344 following internaliza-
tion within macrophages found that bacteria opsonized with com-
plement survived, while those opsonized with Ab were killed [18].
In order to ensure that Salmonellae internalized by blood
phagocytes are viable, we conducted gentamicin protection assays
using S. Typhimurium D23580 that had been opsonized with both
Ab and complement, and washed blood cells. After 45 min of
exposure to blood phagocytes, we found a fourfold increase in
viable Salmonellae in the intracellular compartment by comparing
numbers of viable bacteria following lysis of blood cells or no lysis
(Supporting Information Fig. 2B).
Applicability of findings to invasive African S.
Enteritidis and laboratory strains of S. Typhimurium
and S. Enteritidis
In order to gauge the generalizability of these findings to
other strains of NTS, we repeated the experiments using the
S. Typhimurium laboratory strain SL1344, and S. Enteritidis
African invasive isolate D24954 and laboratory strain PT4. The
same kinetics of Ab-dependent complement-mediated killing and
phagocytic uptake into neutrophils and monocytes were observed
for these three strains as for S. Typhimurium D23580 (Supporting
Information Fig. 2C–E).
Salmonellae can escape to intracellular locations
during the extracellular killing lag period
These findings indicated that there is a period of time that
can act as a window of opportunity for opsonized bacteria to
evade cell-free complement-dependent killing and escape the
extracellular environment into their intracellular niche within
phagocytic cells. The results are consistent with Salmonellae
being rapidly opsonized by specific antibodies and complement
upon entering the bloodstream. Opsonization facilitates faster
uptake by phagocytes, particularly neutrophils [7], allowing the
bacteria to escape potential complement-mediated damage from
MAC formation. Although opsonization also facilitates killing of
bacteria by oxidative burst [7], Salmonellae are adapted to survive
inside phagocytes by utilizing virulence genes encoded in their
pathogenicity islands [19]. Therefore, the ability of a proportion
of Salmonellae to evade the cell-free bactericidal mechanism
during an infective episode is likely to be advantageous to the
bacteria and clinically important.
The effective MAC deposition and Ab-dependent complement-
mediated killing of Salmonellae suggests that sustained bacter-
aemia with high concentrations of bacteria in the presence of
specific antibodies and functional complement is unlikely. This is
consistent with the relatively low blood-borne bacterial numbers
seen in most African adults with NTS bacteraemia [20]. Salmonel-
losis in patients with IL-12/23-IFN-γ axis deficiencies usually
presents as focal extra-intestinal disease, particularly in the cer-
vical lymph nodes. Intracellular densities of Salmonellae in chal-
lenge studies reach higher levels in IFN-γ−/− animals than in WT
controls [11]. Yet, despite the impact on cell-mediated immunity
and associated increased Salmonella growth, patients with
IL-12/23-IFN-γ axis deficiencies do not develop fatal Salmonella
bacteraemia. In contrast, salmonellosis in African infants that lack
specific antibodies presents as a bacteraemia, which is often fatal.
Our data demonstrate that the kinetics of Ab and complement
binding, serum-mediated killing and phagocytosis are consistent
with these clinical observations. The relative delay in maximal
serum-mediated killing compared with phagocytosis permits the
escape and survival of a proportion of Salmonellae, which can
enable continued and potentially chronic infection. Such a model
could explain how complement-fixing Salmonella-specific anti-
bodies are unable to prevent severe and recurrent salmonellosis
in patients with defective cellular immunity, despite their ability
to mediate bactericidal activity [1]. The model is also consistent
with the observation in animals that cell-mediated immunity
is required for the effective ultimate clearance of Salmonellae
following infection [21].
The nearly instantaneous binding of antibodies to Salmonella,
in combination with an opsonic and bactericidal contribution
from complement factors, is likely to prevent persistence of
Salmonellae in the blood. In the in vivo setting, this contribution of
antibodies could be lifesaving and thus a vaccine inducing a robust
Ab response, even in the absence of a strong cellular response,
may prevent mortality caused by invasive NTS disease in Africa.
Indeed, this is likely to be the manner that the T-independent
Vi capsular polysaccharide vaccine against typhoid contributes its
protection. Complementary use of antibiotics with good intracellu-
lar penetration, such as the fluoroquinolones, can lead to effective
clearance of persistent intracellular infection in immunocompe-
tent individuals. Nevertheless, ideally a vaccine against NTS for
Africa, where high numbers of HIV-infected individuals represent
a significant proportion of the susceptible population, would also
induce effective cell-mediated immunity in order to facilitate clear-
ance of intracellular infection and prevent recurrent disease.
Concluding remarks
NTS are a major cause of fatal bacteraemia in sub-Saharan Africa.
The relationship between intracellular and extracellular survival
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of these bacteria in the blood during invasive disease in man is
not well understood. Studies in mice are likely to underestimate
the importance of Ab-dependent complement-mediated cell-free
killing of Salmonellae and so we used in vitro assays with human
serum and blood to investigate this relationship.
Opsonization with C3 occurred rapidly following Ab binding,
but deposition of C5b-9 MAC, required for cell-free killing, was
slower. The differential kinetics of deposition of these complement
components corresponded with a lag between the rapid uptake
of Salmonellae into blood phagocytes and cell-free complement-
mediated killing. This provides an opportunity for Salmonella to
escape into its intracellular niche and establish chronic latent
infection. These findings need to be considered in the design of
optimal vaccine and antibiotic therapies against invasive nonty-
phoidal Salmonella in Africa.
Materials and methods
Salmonellae
Salmonella Typhimurium D23580 and S. Enteritidis D24954
are typical invasive African isolate of NTS and were obtained
from the Malawi-Liverpool-Wellcome Trust Clinical Research Pro-
gramme/College of Medicine in Blantyre, Malawi. Salmonella
Typhimurium SL1344 and S. Enteritidis PT4 are commonly used
laboratory strains of NTS. They are sensitive to killing by human
adult serum, undergoing a one to three log10 kill over a 3 h time
course [6]. D23580 is the index African-specific S. Typhimurium
isolate of the ST 313 pathovar and is representative of over 90%
of NTS isolates from bacteremic individuals in Malawi since 2002
and has been genome sequenced at the Wellcome Trust Sanger
Institute [22].
Materials
Unless otherwise stated, materials were from Sigma. Human sera
were from two healthy Malawian and two healthy European
adults. Serum was separated within 2 h of venesection and stored
in aliquots at −80◦C. Unless otherwise stated, serum was freshly
thawed prior to use in assays in order to maintain integrity of
endogenous complement function. When required, complement
function was inactivated by heating serum at 56◦C for 30 min. No
external sources of complement were used in the study. Ethical
approval for the use of serum samples in this study was granted
by the Life and Health Sciences Ethical Review Committee of the
University of Birmingham. Informed written consent was obtained
from all participants.
Anti-Salmonella Ab assays and complement
deposition assays
These were performed by flow cytometry as described previously
[6]. Briefly, 5μL S. TyphimuriumD23580 in log-growth phasewas
mixed with 45 μL 10% freshly thawed serum for Ab binding, or
undiluted freshly thawed serum for complement deposition (final
Salmonella concentration 2 × 108/mL). FITC-conjugated anti-IgG,
anti-C3, and anti-C5b-9 (MAC) (DAKO) were used for detection
prior to analysis on a FACSCalibur flow cytometer (Becton Dick-
inson, Oxford, UK). Salmonellae were identified by light scatter
characteristics and Salmonella-specific IgG and complement depo-
sition levels were determined as the FL1-H (FITC) geometric MFI.
Salmonella serum bactericidal assays
These were performed as described previously [6]. Briefly, 5 μL
viable S. Typhimurium D23580 in log-growth phase (OD 0.3 at
600 nm)was added to 45μL freshly thawed undiluted serum (final
Salmonella concentration 1 × 106, 1 × 107, and 1 ×108/mL) and
incubated at 37◦C with numbers of viable Salmonellae determined
by serial dilution and plating in triplicate on Luria Bertani agar
at various time points. SBA were performed with heat-inactivated
serum as a control in order to confirm that killing of bacteria was
complement-mediated and that bacterial agglutination had not
led to an artifactual reduction in viable counts.
Phagocytosis assays
These were performed as previously described [7]. Briefly, 10 μL
of 2 × 109/mL FITC-labeled Salmonellae were added to 50 μL of
blood (final concentration 3.3 × 108/mL) and incubated at 37◦C,
with a paired sample maintained at 0◦C. In order to discriminate
internalized and surface-bound bacteria, fluorescence from non-
internalized bacteria was quenched using 50 μL of 0.16% Trypan
blue. FACS lysing solution was used to lyse red blood cells and
fix leukocytes and propidium iodide was added to allow discrim-
ination of leukocytes from free bacteria and cell fragments. Neu-
trophils and monocytes were distinguished by light scatter char-
acteristics. The percentages of neutrophils and monocytes that
had phagocytosed Salmonellae were determined by flow cytome-
try using the FL1-H (FITC) histogram. To confirm the requirement
in the assay of opsonization of Salmonellae with Ab and comple-
ment for uptake into monocytes and neutrophils, a control was
performed using blood cells washed in RPMI to remove Ab and
complement.
Gentamicin protection assays
Salmonella Typhimurium D23580 were opsonized with Ab and
complement by exposure to immune serum for 20 min. They
were then incubated for 10 or 45 min at 37◦C (final concentration
2 × 108/mL) with peripheral blood cells that had been washed
twice with RPMI to remove endogenous Ab and complement. After
this, blood cells were washed twice with RPMI and gentamicin
was added at a final concentration of 1.25 mg/mL. The cells were
incubated for a further 30 min on a rocker plate at 20 rpm to kill
extracellular bacteria. Blood cell suspensions were again washed
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
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twice with RPMI and lysed using 1:10 deionized water for 1 min
or PBS as a nonlysis control. Numbers of viable bacteria released
from blood phagocytes were quantified by serial dilution on agar
plates.
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